Christopher A. Kerfoot

Author

UCLA Medical Center

Also Known As

C. Kerfoot, Christopher A Kerfoot, Christopher A. Kerfoot, Christopher Kerfoot

Publications

579

Citations

H-Index

Concepts

All Affiliations

UCLA Medical Center National Cancer Institute

About

Christopher A. Kerfoot is an author at UCLA Medical Center specializing in medicine, physiology, and cellular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	93
2	Cell Biology	1	1	33
3	Cellular Physiology	1	1	60
4	Immunology	1	1	33
5	Pharmacology	1	1	33

Christopher A. Kerfoot

Publications

487

Citations

H-Index

Page 1

	Year	Citations
Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study Sung‐Hye Park, Samuel H. Pepkowitz, Christopher A. Kerfoot, Acta Neuropathologica Fetal MedicinePediatricsMaternal HealthFetal NeurodevelopmentFetal Complication	1997	98
An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo Shafaat A. Rabbani, Bushra Ateeq, Ani Arakelian, Neoplasia	2010	86
Immunohistochemical Analysis of Advanced Human Breast Carcinomas Reveals Downregulation of Protein Kinase Cα Christopher A. Kerfoot, Weidong Huang, Susan A. Rotenberg Journal of Histochemistry & Cytochemistry	2004	66
Hamartin and Tuberin Expression in Human Tissues Michael W. Johnson, Christopher A. Kerfoot, Theodore Bushnell, Modern Pathology Biomedical ResearchPhysiologyHuman TissueTuberin ExpressionMedicine	2001	60
Localization of Tuberous Sclerosis 2 mRNA and its Protein Product Tuberin in Normal Human Brain and in Cerebral Lesions of Patients with Tuberous Sclerosis Christopher A. Kerfoot, Ralf Wienecke, Michael Menchine, Brain Pathology	1996	60
Cerebral Cortical Dysplasia: Giant Neurons Show Potential for Increased Excitation and Axonal Plasticity Christopher A. Kerfoot, Harry V. Vinters, Gary W. Mathern Developmental Neuroscience	1999	55
In vitro and ex vivo activity of SDX-105 (bendamustine) in drug-resistant lymphoma cells Lorenzo M. Leoni, Brandi Bailey, Christina C. Niemeyer, Cancer Research ImmunologyCancer BiologyTumor BiologyDrug-resistant Lymphoma CellsDisc® Assay	2004	33
Level of phosphohistone H3 among various types of human cancers Amy Sun, Wei Zhou, Jared Lunceford, BMJ Open	2012	29

Page 1